Novartis CEO Vas Narasimhan restructures the pharma giant, cutting
- Novartis CEO Vas Narasimhan restructures the pharma giant, cutting costs $1B+, ousting top execs and signaling layoffs ahead Endpoints News
- In major shake-up, Novartis combines pharma, oncology units, leaving cancer commercial head, CMO out of job FiercePharma
- CMO John Tsai exits, as Novartis starts revamp that aims to save $1bn – pharmaphorum
- Novartis to save at least $1 billion by 2024 thanks to simplified structure Reuters.com
- Novartis says bye to Tsai as restructuring triggers the return of a familiar face FierceBiotech
- View Full Coverage on Google News
Read More: Novartis CEO Vas Narasimhan restructures the pharma giant, cutting